157 related articles for article (PubMed ID: 6951665)
1. Antibody-dependent cellular cytotoxicity of leukaemic blast cells and neutrophils from patients with acute myelogenous leukaemia.
Dallegri F; Holm G; Gahrton G
Clin Exp Immunol; 1982 Feb; 47(2):414-8. PubMed ID: 6951665
[TBL] [Abstract][Full Text] [Related]
2. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
Richter M; Banerjee D; Sklar S
Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-mediated antibody-dependent cellular cytotoxicity against erythrocytes. Mechanisms of target cell destruction.
Dallegri F; Patrone F; Holm G; Gahrton G; Sacchetti C
Clin Exp Immunol; 1983 Jun; 52(3):613-9. PubMed ID: 6307559
[TBL] [Abstract][Full Text] [Related]
4. Antibody-dependent haemolytic activity of human leukaemic cells.
Holm G; Björkholm M; Böttiger B; Mellstedt H; Pettersson D; Simonsson-Lindemalm C
Clin Exp Immunol; 1980 Oct; 42(1):121-6. PubMed ID: 7460388
[TBL] [Abstract][Full Text] [Related]
5. [Antibody-dependent cell-mediated cytotoxicity of peripheral blood neutrophils in vitro in acute leukemia].
Guseva SA
Tsitologiia; 1985 Sep; 27(9):1067-70. PubMed ID: 2997955
[TBL] [Abstract][Full Text] [Related]
6. Antibody-dependent cell-mediated cytotoxicity by human lymphocytes. II. Comparison with polymorphonuclear leukocytes against erythrocyte and nucleated target cells.
Fuson EW; Shaw MW; Hubbard RA; Sugantharaj DG; Lamon EW
Exp Hematol; 1981 Feb; 9(2):197-206. PubMed ID: 7238651
[TBL] [Abstract][Full Text] [Related]
7. [Antibody-dependent cytotoxicity of lymphocytes in acute myeloblastic leukemia and chronic myelocytic leukemia].
Tishchenko LM; Guseva SA
Eksp Onkol; 1987; 9(2):66-7. PubMed ID: 3472877
[TBL] [Abstract][Full Text] [Related]
8. Analysis of cytotoxic effector cell function in patients with leukemia or aplastic anemia before and after marrow transplantation.
Livnat S; Seigneuret M; Storb R; Prentice RL
J Immunol; 1980 Jan; 124(1):481-90. PubMed ID: 6765970
[TBL] [Abstract][Full Text] [Related]
9. Role of the oxidative metabolic burst in the antibody-dependent cellular cytotoxicity mediated by neutrophil polymorphonuclears.
Dallegri F; Frumento G; Minervini F; Muttini P; Patrone F
Exp Hematol; 1982 Nov; 10(10):859-66. PubMed ID: 6295791
[TBL] [Abstract][Full Text] [Related]
10. Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251 x 22 (anti-CD33 x anti-CD64).
Chen J; Zhou JH; Ball ED
Clin Cancer Res; 1995 Nov; 1(11):1319-25. PubMed ID: 9815927
[TBL] [Abstract][Full Text] [Related]
11. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
Ball ED; Kadushin JM; Schacter B; Fanger MW
J Immunol; 1982 Mar; 128(3):1476-81. PubMed ID: 6948897
[TBL] [Abstract][Full Text] [Related]
12. The antibody-independent cytotoxic activity of normal circulating human leucocytes. I. Lysis of target cells by monocytes and neutrophils in a non-phagocytic pathway.
Banerjee D; Fernando L; Sklar S; Richter M
Immunology; 1981 Sep; 44(1):97-107. PubMed ID: 7275189
[TBL] [Abstract][Full Text] [Related]
13. The effect of recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor on Fc gamma receptor expression and antibody-dependent cellular cytotoxicity of hematopoietic progenitor cells during in vitro myeloid maturation.
Ericson SG; Benoit NE; Mills LE; Fanger MW
Exp Hematol; 1994 Mar; 22(3):283-9. PubMed ID: 7509291
[TBL] [Abstract][Full Text] [Related]
14. Distinct functions of surface receptors in the induction of neutrophil-mediated cytotoxicity.
Cordier G; Samarut C; Revillard JP
Ann Immunol (Paris); 1981; 132D(1):3-14. PubMed ID: 7347555
[TBL] [Abstract][Full Text] [Related]
15. Cellular and humoral cytotoxicity in patients with leukaemia and preleukaemia. II. Oncovirus specificity of the reaction.
Szabó B; Tóth FD; Váczi L; Réthy A; Kiss A; Rák K
Acta Microbiol Hung; 1984; 31(4):365-72. PubMed ID: 6085606
[TBL] [Abstract][Full Text] [Related]
16. Natural killer activity in patients with acute myelocytic leukemia.
Stupp Y; Rosenkovitch E; Izak G
Isr J Med Sci; 1978 Dec; 14(12):1212-5. PubMed ID: 311767
[TBL] [Abstract][Full Text] [Related]
17. Expression of blood group-like antigens on the T lymphocytes of acute leukaemia patients in remission.
Pullen S; Hersey P
Clin Exp Immunol; 1980 Feb; 39(2):403-10. PubMed ID: 6966993
[TBL] [Abstract][Full Text] [Related]
18. Antibody-dependent monocyte-mediated cytotoxicity. Serial studies in acute myeloid leukaemia.
Kragballe K; Ellegaard J
Scand J Haematol; 1980 Aug; 25(2):181-90. PubMed ID: 6936773
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of decreased antibody-dependent cytotoxicity mediated by monocytes and neutrophils in atopic dermatitis.
Kragballe K; Borregaard N
Acta Derm Venereol; 1981; 61(1):11-15. PubMed ID: 6164208
[TBL] [Abstract][Full Text] [Related]
20. [Effect of prodigiozan on the antibody-dependent cytotoxicity of neutrophils in chronic myeloid leukemia].
Guseva SA; Tishchenko LM
Vopr Onkol; 1989; 35(1):30-4. PubMed ID: 2521967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
